Skip to main content
Fig. 3 | Journal of Pharmaceutical Health Care and Sciences

Fig. 3

From: Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study

Fig. 3

Classification of the included patients by the number of concomitant medications that have DDIs with NMV-r. Each number in the legend indicates the number of concomitant medications that have DDIs with NMV-r. Patients with insufficient details on concomitant medications were separately classified. DDIs, drug-drug interactions; MOV, molnupiravir; NMV-r, nirmatrelvir/ritonavir

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us